Sponsored

North America Molecular Diagnostics Market to be Worth $18.13 Billion by 2030
North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User - Forecast to 2030
________________________________________
Meticulous Research®, a leading global market research company, published a research report titled, ‘North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User—Forecast to 2030.’
According to this latest publication from Meticulous Research®, the North America molecular diagnostics market is expected to reach $18.13 billion by 2030 at a CAGR of 5.3% from 2023 to 2030. The growth of the North America molecular diagnostics market is driven by several factors, including the rising geriatric population, the increasing prevalence of communicable & non-communicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditures. However, unfavorable regulatory frameworks and the high costs of molecular diagnostic tests restrain the growth of this market.
Furthermore, increasing focus on companion diagnostics and the rising popularity of direct-to-consumer (DTC) genetic testing are expected to create growth opportunities for the players in this market. However, the shortage of skilled professionals is a major challenge for market growth. Additionally, the rising integration of artificial intelligence & machine learning is a prominent trend in the molecular diagnostics market.
Key Players
The key players operating in the North America molecular diagnostics market are Hologic, Inc. (U.S.), Danaher Corporation (U.S.), BioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), QIAGEN N.V. (Netherlands), and Seegene, Inc. (South Korea).
North America Molecular Diagnostics Market: Future Outlook
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5642


Have Any Query? Ask To Analyst:
https://www.meticulousresearch.com/speak-to-analyst/cp_id=5642
Geographic Review
This research report comprehensively analyzes the major countries in North America (U.S. and Canada). In 2023, the U.S. is expected to account for the largest share of the North America molecular diagnostics market. In the U.S., the number of people aged 65 and above is increasing rapidly. The number of senior citizens is projected to increase from 56.0 million in 2020 to 94.7 million in 2060. Additionally, the number of people aged 85 and above is projected to nearly triple from 6.7 million in 2020 to 19.0 million by 2060. The aging population is vulnerable to various diseases and is more likely to go to the hospital for infectious diseases. In addition, the aging population is prone to Alzheimer’s disease and other types of dementia and is more likely to be hospitalized. Hence, the growing geriatric population will require frequent diagnostic testing, increasing the demand for molecular diagnostic products.
Quick Buy: https://www.meticulousresearch.com/Checkout/41114062
Key questions answered in the report-
• Which are the high-growth market segments in terms of product & service, test type, technology, application, end user, and geography?
• What was the historical market for molecular diagnostics across North America?
• What are the market forecasts and estimates for the period 2023–2030?
• What are the major drivers, restraints, opportunities, and challenges in the North America molecular diagnostics market?
• Who are the major players in the North America molecular diagnostics market?
• What is the competitive landscape, and who are the market leaders in the North America molecular diagnostics market?
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5642

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

North America Molecular Diagnostics Market to be Worth $18.13 Billion by 2030 North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User - Forecast to 2030 ________________________________________ Meticulous Research®, a leading global market research company, published a research report titled, ‘North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User—Forecast to 2030.’ According to this latest publication from Meticulous Research®, the North America molecular diagnostics market is expected to reach $18.13 billion by 2030 at a CAGR of 5.3% from 2023 to 2030. The growth of the North America molecular diagnostics market is driven by several factors, including the rising geriatric population, the increasing prevalence of communicable & non-communicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditures. However, unfavorable regulatory frameworks and the high costs of molecular diagnostic tests restrain the growth of this market. Furthermore, increasing focus on companion diagnostics and the rising popularity of direct-to-consumer (DTC) genetic testing are expected to create growth opportunities for the players in this market. However, the shortage of skilled professionals is a major challenge for market growth. Additionally, the rising integration of artificial intelligence & machine learning is a prominent trend in the molecular diagnostics market. Key Players The key players operating in the North America molecular diagnostics market are Hologic, Inc. (U.S.), Danaher Corporation (U.S.), BioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), QIAGEN N.V. (Netherlands), and Seegene, Inc. (South Korea). North America Molecular Diagnostics Market: Future Outlook Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5642 Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5642 Geographic Review This research report comprehensively analyzes the major countries in North America (U.S. and Canada). In 2023, the U.S. is expected to account for the largest share of the North America molecular diagnostics market. In the U.S., the number of people aged 65 and above is increasing rapidly. The number of senior citizens is projected to increase from 56.0 million in 2020 to 94.7 million in 2060. Additionally, the number of people aged 85 and above is projected to nearly triple from 6.7 million in 2020 to 19.0 million by 2060. The aging population is vulnerable to various diseases and is more likely to go to the hospital for infectious diseases. In addition, the aging population is prone to Alzheimer’s disease and other types of dementia and is more likely to be hospitalized. Hence, the growing geriatric population will require frequent diagnostic testing, increasing the demand for molecular diagnostic products. Quick Buy: https://www.meticulousresearch.com/Checkout/41114062 Key questions answered in the report- • Which are the high-growth market segments in terms of product & service, test type, technology, application, end user, and geography? • What was the historical market for molecular diagnostics across North America? • What are the market forecasts and estimates for the period 2023–2030? • What are the major drivers, restraints, opportunities, and challenges in the North America molecular diagnostics market? • Who are the major players in the North America molecular diagnostics market? • What is the competitive landscape, and who are the market leaders in the North America molecular diagnostics market? Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5642 Contact Us: Meticulous Research® Email- [email protected] Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
0 Comments 0 Shares
Sponsored

Sponsored

Don't forget, ads time: PentaVerge | AQU | Debwan | ICICTE | Nasseej | ESol | OUST | CorpSNet | PoemsBook | TopDeals | TheReaderView